Eledon Pharmaceuticals (ELDN) News Today $2.60 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.60 +0.00 (+0.19%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELDN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial ResultsAugust 14 at 4:20 PM | globenewswire.comEledon Pharmaceuticals (ELDN) to Release Earnings on MondayAugust 12 at 4:34 AM | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Eledon Pharmaceuticals (ELDN), Voyager Therapeutics (VYGR)August 11 at 5:09 PM | theglobeandmail.comEledon Pharmaceuticals Reports Promising Phase 1b Trial ResultsAugust 11 at 5:09 PM | theglobeandmail.comEledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney TransplantationAugust 6, 2025 | globenewswire.comEledon Pharmaceuticals to Present Updated Clinical Data for Tegoprubart at World Transplant CongressJuly 31, 2025 | msn.comEledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025July 30, 2025 | globenewswire.comCraig Hallum Begins Coverage on Eledon Pharmaceuticals (NASDAQ:ELDN)July 26, 2025 | marketbeat.comCraig-Hallum Initiates Coverage of Eledon Pharmaceuticals (ELDN) with Buy RecommendationJuly 26, 2025 | msn.comCraig-Hallum bullish on Eledon Pharmaceuticals, initiates with a BuyJuly 25, 2025 | msn.comUpdated Data from Eledon Pharmaceuticals' Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025July 17, 2025 | globenewswire.comWhat is Lifesci Capital's Estimate for ELDN Q2 Earnings?July 14, 2025 | marketbeat.comEledon Pharmaceuticals Rings the Closing BellJuly 9, 2025 | nasdaq.comEledon Pharmaceuticals Inc (ELDN) Stock Forums - Investing.comJune 29, 2025 | investing.comEledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York CityJune 25, 2025 | globenewswire.comWhat is HC Wainwright's Estimate for ELDN Q2 Earnings?June 23, 2025 | marketbeat.comAnalysts Issue Forecasts for ELDN Q1 EarningsJune 19, 2025 | marketbeat.comEledon Pharmaceuticals' (ELDN) "Buy" Rating Reaffirmed at HC WainwrightJune 18, 2025 | marketbeat.comBank of America Corp DE Increases Stock Holdings in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)June 13, 2025 | marketbeat.comMillennium Management LLC Invests $490,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)June 9, 2025 | marketbeat.comEledon Pharmaceuticals (NASDAQ:ELDN) Downgraded by Wall Street Zen to "Sell"June 6, 2025 | marketbeat.comEledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Down 12.3% in MayJune 4, 2025 | marketbeat.comJane Street Group LLC Makes New $504,000 Investment in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 31, 2025 | marketbeat.comWoodline Partners LP Boosts Stake in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 26, 2025 | marketbeat.comEledon Pharmaceuticals (NASDAQ:ELDN) Rating Increased to Hold at Wall Street ZenMay 24, 2025 | marketbeat.com1,100,473 Shares in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Acquired by AWM Investment Company Inc.May 23, 2025 | marketbeat.comEquities Analysts Offer Predictions for ELDN Q2 EarningsMay 23, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Invests $4.85 Million in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 23, 2025 | marketbeat.comZimmer Partners LP Has $3.09 Million Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 23, 2025 | marketbeat.comPoint72 Asset Management L.P. Purchases New Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 22, 2025 | marketbeat.comVelan Capital Investment Management LP Purchases New Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 21, 2025 | marketbeat.comFY2025 EPS Estimates for ELDN Boosted by Cantor FitzgeraldMay 21, 2025 | marketbeat.comQ2 EPS Estimate for Eledon Pharmaceuticals Lifted by AnalystMay 20, 2025 | marketbeat.comSphera Funds Management LTD. Buys 1,254,298 Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 18, 2025 | marketbeat.comCantor Fitzgerald maintains Overweight on Eledon Pharmaceuticals stockMay 17, 2025 | uk.investing.comEledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Shares Purchased by Ensign Peak Advisors IncMay 17, 2025 | marketbeat.comEledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial ResultsMay 14, 2025 | globenewswire.comAlyeska Investment Group L.P. Increases Stake in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 8, 2025 | marketbeat.comMarshall Wace LLP Invests $331,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 7, 2025 | marketbeat.comEledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Sees Large Increase in Short InterestMay 5, 2025 | marketbeat.comAllostery Investments LP Makes New Investment in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 4, 2025 | marketbeat.com683 Capital Management LLC Takes Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 4, 2025 | marketbeat.com235,750 Shares in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Acquired by Acuta Capital Partners LLCMay 4, 2025 | marketbeat.comEledon: A Company With Good Early Data In Kidney Transplant Rejection And A Full Balance SheetMay 3, 2025 | seekingalpha.comRA Capital Management L.P. Acquires New Shares in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 3, 2025 | marketbeat.comEledon Pharmaceuticals (ELDN) to Release Earnings on ThursdayMay 3, 2025 | marketbeat.comEledon Pharmaceuticals, Inc. (NASDAQ:ELDN) has caught the attention of institutional investors who hold a sizeable 46% stakeMay 2, 2025 | finance.yahoo.comBoothbay Fund Management LLC Buys New Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)May 1, 2025 | marketbeat.comNantahala Capital Management LLC Raises Stock Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)April 30, 2025 | marketbeat.comFirst Light Asset Management LLC Takes Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)April 30, 2025 | marketbeat.com Get Eledon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELDN and its competitors with MarketBeat's FREE daily newsletter. Email Address ELDN Media Mentions By Week ELDN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELDN News Sentiment▼0.280.61▲Average Medical News Sentiment ELDN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELDN Articles This Week▼72▲ELDN Articles Average Week Get Eledon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELDN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GHRS News Today SIGA News Today MGTX News Today DAWN News Today AUTL News Today KALV News Today AVBP News Today DNTH News Today VIR News Today ANAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELDN) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eledon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eledon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access